Press releases

1 2 3 29

BD Unveils Platelet Quality Control Media to Help Reduce the Incidence of Sepsis in Patients Requiring Platelet Transfusion

Apr 8, 2019

BD Unveils Platelet Quality Control Media to Help Reduce the Incidence of Sepsis in Patients Requiring Platelet Transfusion

BD Launches New Automated Flow Cytometry Sample Preparation Instrument with CE-IVD Certification

Mar 26, 2019

BD Launches New Automated Flow Cytometry Sample Preparation Instrument with CE-IVD Certification

BD Statement on Paclitaxel-Coated Devices

Mar 21, 2019

BD Statement on Paclitaxel-Coated Devices

BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease

Mar 14, 2019

BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease

BD Advances Technology to Create Endovascular AV Fistulas for Chronic Kidney Disease Patients Who Require Hemodialysis

Feb 13, 2019

BD WavelinQ 4F EndoAVF System Receives 510(k) Clearance from U.S. Food and Drug Administration

BD Announces Results for 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

Feb 5, 2019

BD Announces Results for 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

BD Launches Ergonomic Pen Needle Technology to Help Optimize Injection Technique

Jan 24, 2019

BD Nano™ Second Generation Pen Needle Receives 510(k) Clearance from U.S. Food and Drug Administration

BD Completes Molecular Portfolio For GI Infection With New Viral Panel

Dec 20, 2018

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration 510(k) clearance of its BD MAX enteric viral panel, a molecular diagnostic test for the direct qualitative detection and differentiation of enteric viral pathogens that cause viral gastroenteritis.

BD Announces completion of enterprise level cybersecurity assessment from UL

Dec 11, 2018

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the completion of an enterprise level cybersecurity assessment from UL.

BD Expands Integrated Medication Management to Help Tackle Hospital Drug Diversion

Nov 29, 2018

Learn how advanced analytics can help combat a critical component of the opioid epidemic at the #ASHP18 Midyear Meeting

1 2 3 29